Morphine Self-administration into the Lateral Septum Depends on Dopaminergic Mechanisms: Evidence from Pharmacology and Fos Neuroimaging.
From: Centre de Neurosciences Intégratives et Cognitives, Universités Bordeaux 1 et 2, UMR CNRS 5228, Avenue des Facultés, 33405 Talence, France. lemerrer@igbmc.u-strasbg.fr
Behavioural brain research
- Publish Date: Jun 2007
- ISSN: 0166-4328
- Volume: 180
- Issue: 2
- Pages: 203-17
- Medium: Print
- Language: English
- Citation (JAMA): Le Merrer Julie, Gavello-Baudy Stéphanie, Galey Daniel, et al. Morphine Self-administration into the Lateral Septum Depends on Dopaminergic Mechanisms: Evidence from Pharmacology and Fos Neuroimaging.. Behav. Brain Res. Jun 2007;180:203-17
Abstract
Mice self-administer morphine into the lateral septum (LS), but the neuronal connections underlying this behaviour remain unknown. The present study tested whether the acquisition of intra-LS morphine self-administration depends on dopaminergic mechanisms. Mice were allowed to self-inject morphine (5 or 20ng/50nl) or vehicle directly into the LS using a spatial discrimination Y-maze task. Fos imaging was used to evaluate neuronal activation in cerebral structures directly connected to the LS or belonging to the dopaminergic system. The involvement of dopaminergic and opioidergic mechanisms was assessed by pre-treating naive mice peripherally with the D1 antagonist SCH23390, the D2/D3 antagonist sulpiride or the opiate antagonist naloxone before daily self-administration sessions. Mice acquired self-administration behaviour for intra-LS morphine that was associated with increased Fos expression in the ventral tegmental area (VTA), dorsal and ventral striatum and prefrontal cortex. Pre-treating animals with naloxone, SCH23390 or sulpiride completely prevented them from acquiring intra-LS morphine self-administration. All three antagonists consistently blocked Fos expression in the prefrontal cortex, but not in the VTA and striatum. Taken together, our results show that morphine self-administration into the LS depends on dopaminergic (D1 and D2/D3) and opioidergic mechanisms. Furthermore, they suggest that opioid peptides released in the LS could participate in regulating the activity of mesotegmental dopaminergic neurons.
Mesh Headings (Keywords): (R)-2,3,4,5-Tetrahydro-8-chloro-3-methyl-5-phenyl-1H-3-benzazepin-7-ol, Analysis of Variance, Animals, Behavior, Animal, Cell Count, Choice Behavior, Dopamine, Dopamine Antagonists, Dose-Response Relationship, Drug, Male, Maze Learning, Mice, Mice, Inbred BALB C, Morphine, Naloxone, Narcotic Antagonists, Narcotics, Oncogene Proteins v-fos, Reaction Time, Self Administration, Septal Nuclei, Sulpiride
Check for Full Text / PubMed Unique Identifier (PMID): 17467070
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.